HCM FY 2021 Earnings — HUTCHMED (China) Limited Revenue & Financial Results | Market Cap Arena

HCMHUTCHMED (China) Limited

$3B

FY 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$356M+56.2% YoY

Gross Profit

$98M27.5% margin

Operating Income

-$344M-96.7% margin

Net Income

-$195M-54.7% margin

EPS (Diluted)

$-1.25

Cash Flow

Operating Cash Flow

-$204M

Free Cash Flow

-$221M

Stock-Based Comp.

$42M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$333M

Stockholders' Equity

$987M

Cash & Equivalents

$378M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$356M	$228M	+56.2%
Gross Profit	$98M	$39M	+148.1%
Operating Income	-$344M	-$199M	-73.3%
Net Income	-$195M	-$126M	-54.8%